Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
F-box and WD repeat domain containing 12 pseudogene (FBXW12 pseudogene) is classified as a pseudogene and is non-protein coding[1]. Pseudogenes are genomic elements related to functional genes but are generally considered *nonfunctional* due to the accumulation of disabling mutations and the lack of expression of a functional protein product. There is no evidence this pseudogene encodes a functional protein or is involved in canonical molecular or cellular functions, and it is not considered a valid therapeutic target. Additionally, as a pseudogene, it does not have known disease associations, interacting drugs, or established safety concerns for drug development. In summary, this entry is **not a therapeutic target** but rather a **nonfunctional pseudogene**, and its presence in target gene lists may be due to annotation errors or misunderstandings about its nature[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on F-box and WD repeat domain containing 12 pseudogene (FBXW12 pseudogene).